دورية أكاديمية

Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir

التفاصيل البيبلوغرافية
العنوان: Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir
المؤلفون: Naohiro Oda, Keiji Miyoshi, Daisuke Morichika, Yuka Beika, Takahiro Taki, Reo Mitani, Toshiaki Okada, Ichiro Takata
المصدر: Clinical Case Reports, Vol 9, Iss 7, Pp n/a-n/a (2021)
بيانات النشر: Wiley, 2021.
سنة النشر: 2021
المجموعة: LCC:Medicine
LCC:Medicine (General)
مصطلحات موضوعية: baricitinib, COVID‐19, immune checkpoint inhibitor, immune‐related adverse event, lung cancer, Medicine, Medicine (General), R5-920
الوصف: Abstract COVID‐19 in cancer patients on immunosuppressive agents for the treatment of immune‐related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID‐19, and further clinical trials are warranted.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2050-0904
Relation: https://doaj.org/toc/2050-0904
DOI: 10.1002/ccr3.4459
URL الوصول: https://doaj.org/article/e1cf2529d28f48dfb3f0dab67d7fb366
رقم الأكسشن: edsdoj.1cf2529d28f48dfb3f0dab67d7fb366
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20500904
DOI:10.1002/ccr3.4459